Abstract
The coronavirus disease 2019 (COVID-19) pandemic has been a significant concern worldwide. The pandemic has demonstrated that public health issues are not merely a health concern but also affect society as a whole. In this chapter, we address the importance of bringing together the world’s scientists to find appropriate solutions for controlling and managing the COVID-19 pandemic. Interdisciplinary cooperation, through modern scientific methods, could help to handle the consequences of the pandemic and to avoid the recurrence of future pandemics.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adamu H, Muhammad M, Jingi A, Usman M (2019) Mathematical modelling using improved SIR model with more realistic assumptions. Int J Eng Appl Sci (IJEAS) 6. https://doi.org/10.31873/IJEAS.6.1.22
Aderem A, Adkins JN, Ansong C, Galagan J, Kaiser S, Korth MJ, Law GL, McDermott JG, Proll SC, Rosenberger C, Schoolnik G, Katze MG (2011) A systems biology approach to infectious disease research: innovating the pathogen-host research paradigm. mBio 2(1):e00325-00310. https://doi.org/10.1128/mBio.00325-10
Ahanchian H, Moazzen N, Faroughi MSD, Khalighi N, Khoshkhui M, Aelami MH, Haghi NSM, Rezaei N (2020) COVID-19 in a child with primary specific antibody deficiency
Ahmadi M, Saffarzadeh N, Habibi MA, Hajiesmaeili F, Rezaei N (2020) Colon cancer and SARS-CoV-2: impact of ACE2 expression in susceptibility to COVID-19. bioRxiv
Ahmed SF, Quadeer AA, McKay MR (2020a) Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies. Viruses 12(3):254. https://doi.org/10.3390/v12030254
Ahmed SF, Quadeer AA, McKay MR (2020b) Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies. Viruses 12(3). https://doi.org/10.3390/v12030254
Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, Lee M (2020) Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA. https://doi.org/10.1001/jama.2020.4326
Ariana-tech (2020, February 1) Data science and crisis management. http://www.ariana-tech.com/
Arthur RF, Gurley ES, Salje H, Bloomfield LS, Jones JH (2017) Contact structure, mobility, environmental impact and behaviour: the importance of social forces to infectious disease dynamics and disease ecology. Philos Trans R Soc Lond Ser B Biol Sci 372(1719). https://doi.org/10.1098/rstb.2016.0454
Babaha F, Rezaei N (2020) Primary immunodeficiency diseases in COVID-19 pandemic: a predisposing or protective factor? Am J Med Sci. https://doi.org/10.1016/j.amjms.2020.07.027
Bago B, Rand DG, Pennycook G (2020) Fake news, fast and slow: deliberation reduces belief in false (but not true) news headlines. J Exp Psychol Gen. https://doi.org/10.1037/xge0000729
Bahrami A, Vafapour M, Moazzami B, Rezaei N (2020) Hyperinflammatory shock related to COVID-19 in a patient presenting with multisystem inflammatory syndrome in children: first case from Iran. J Paediatr Child Health. https://doi.org/10.1111/jpc.15048
Banas JA, Rains SA (2010) A meta-analysis of research on inoculation theory. Commun Monogr 77(3):281–311. https://doi.org/10.1080/03637751003758193
Basiri A, Heidari A, Nadi MF, Fallahy MTP, Nezamabadi SS, Sedighi M, Saghazadeh A, Rezaei N (2020a) Microfluidic devices for detection of RNA viruses. Rev Med Virol n/a(n/a):e2154. https://doi.org/10.1002/rmv.2154
Basiri A, Pazhouhnia Z, Beheshtizadeh N, Hoseinpour M, Saghazadeh A, Rezaei N (2020b) Regenerative medicine in COVID-19 treatment: real opportunities and range of promises. Stem Cell Rev Rep:1–13. https://doi.org/10.1007/s12015-020-09994-5
Bedford J, Enria D, Giesecke J, Heymann DL, Ihekweazu C, Kobinger G, Lane HC, Memish Z, Oh M-D, Sall AA, Schuchat A, Ungchusak K, Wieler LH (2020) COVID-19: towards controlling of a pandemic. Lancet (London, England) 395(10229):1015–1018
Bobdey S, Ray S (2020) Going viral – Covid-19 impact assessment: a perspective beyond clinical practice. J Mar Med Soc 22:9. https://doi.org/10.4103/jmms.jmms_12_20
Bollyky TJ, Gostin LO, Hamburg MA (2020) The equitable distribution of COVID-19 therapeutics and vaccines. JAMA. https://doi.org/10.1001/jama.2020.6641
Bourouiba L, Dehandschoewercker E, Bush John WM (2014) Violent expiratory events: on coughing and sneezing. J Fluid Mech 745:537–563. https://doi.org/10.1017/jfm.2014.88
Cao W, Li T (2020) COVID-19: towards understanding of pathogenesis. Cell Res 30(5):367–369. https://doi.org/10.1038/s41422-020-0327-4
Cauchemez S, Bhattarai A, Marchbanks TL, Fagan RP, Ostroff S, Ferguson NM, Swerdlow D (2011) Role of social networks in shaping disease transmission during a community outbreak of 2009 H1N1 pandemic influenza. Proc Natl Acad Sci 108(7):2825–2830. https://doi.org/10.1073/pnas.1008895108
Chen W-H, Strych U, Hotez PJ, Bottazzi ME (2020a) The SARS-CoV-2 vaccine pipeline: an overview. Curr Trop Med Rep:1–4. https://doi.org/10.1007/s40475-020-00201-6
Chen WH, Strych U, Hotez PJ, Bottazzi ME (2020b) The SARS-CoV-2 vaccine pipeline: an overview. Curr Trop Med Rep:1–4. https://doi.org/10.1007/s40475-020-00201-6
Chen Y, Liu Q, Guo D (2020c) Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol 92(4):418–423. https://doi.org/10.1002/jmv.25681
Christakos G, Olea RA, Serre ML, Yu H-L, Wang L-L (2005) Interdisciplinary public health reasoning and epidemic modelling: the case of black death. Springer, Berlin/Heidelberg
Dansu EJ, Seno H (2019) A model for epidemic dynamics in a community with visitor subpopulation. J Theor Biol 478:115–127. https://doi.org/10.1016/j.jtbi.2019.06.020
Darbeheshti F, Rezaei N (2020) Genetic predisposition models to COVID-19 infection. Med Hypotheses 142:109818. https://doi.org/10.1016/j.mehy.2020.109818
Dimant E, Schulte T (2019) The nature of corruption: an interdisciplinary perspective. German Law J 17(1):53–72. https://doi.org/10.1017/S2071832200019684
Emma Grey Ellis (2020, February 24) The coronavirus outbreak is a petri dish for conspiracy theories
Enwemeka CS, Bumah VV, Masson-Meyers DS (2020) Light as a potential treatment for pandemic coronavirus infections: a perspective. J Photochem Photobiol B Biol 207:111891. https://doi.org/10.1016/j.jphotobiol.2020.111891
EPFL Scientists (2020, April 30) COVID-19: using wastewater to track the pandemic. https://neurosciencenews.com/coronavirus-waste-water-16301/
Ewald J, Sieber P, Garde R, Lang SN, Schuster S, Ibrahim B (2020) Trends in mathematical modeling of host-pathogen interactions. Cell Mol Life Sci 77(3):467–480. https://doi.org/10.1007/s00018-019-03382-0
Fathi N, Rezaei N (2020) Lymphopenia in COVID-19: therapeutic opportunities. Cell Biol Int 44(9):1792–1797. https://doi.org/10.1002/cbin.11403
Godin B (2006) The linear model of innovation: the historical construction of an analytical framework. Sci Technol Hum Values 31(6):639–667. https://doi.org/10.1177/0162243906291865
Hanaei S, Rezaei N (2020) COVID-19: developing from an outbreak to a pandemic. Arch Med Res. https://doi.org/10.1016/j.arcmed.2020.04.021
Hartley DM, Perencevich EN (2020) Public health interventions for COVID-19: emerging evidence and implications for an evolving public health crisis. JAMA
Hawkley LC, Cacioppo JT (2010) Loneliness matters: a theoretical and empirical review of consequences and mechanisms. Ann Behav Med 40(2):218–227. https://doi.org/10.1007/s12160-010-9210-8
Hawryluck L, Gold WL, Robinson S, Pogorski S, Galea S, Styra R (2004) SARS control and psychological effects of quarantine, Toronto, Canada. Emerg Infect Dis 10(7):1206–1212. https://doi.org/10.3201/eid1007.030703
Holmes EA, O’Connor RC, Perry VH, Tracey I, Wessely S, Arseneault L, Ballard C, Christensen H, Cohen Silver R, Everall I, Ford T, John A, Kabir T, King K, Madan I, Michie S, Przybylski AK, Shafran R, Sweeney A, Worthman CM, Yardley L, Cowan K, Cope C, Hotopf M, Bullmore E (2020) Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry 7(6):547–560. https://doi.org/10.1016/S2215-0366(20)30168-1
Huang H, Fan C, Li M, Nie HL, Wang FB, Wang H, Wang R, Xia J, Zheng X, Zuo X, Huang J (2020a) COVID-19: a call for physical scientists and engineers. ACS Nano 14(4):3747–3754. https://doi.org/10.1021/acsnano.0c02618
Huang L, Zhang X, Zhang X, Wei Z, Zhang L, Xu J, Liang P, Xu Y, Zhang C, Xu A (2020b) Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16–23 years outside Wuhan and characteristics of young patients with COVID-19: a prospective contact-tracing study. J Infect 80(6):e1–e13. https://doi.org/10.1016/j.jinf.2020.03.006
Huang X, Wei F, Hu L, Wen L, Chen K (2020c) Epidemiology and clinical characteristics of COVID-19. Arch Iran Med 23(4):268–271. https://doi.org/10.34172/aim.2020.09
Huppert A, Katriel G (2013) Mathematical modelling and prediction in infectious disease epidemiology. Clin Microbiol Infect 19(11):999–1005. https://doi.org/10.1111/1469-0691.12308
Ioannidis J (2020) The infection fatality rate of COVID-19 inferred from seroprevalence data. medRxiv.: 2020.2005.2013.20101253. https://doi.org/10.1101/2020.05.13.20101253
Jabbari P, Rezaei N (2020) With risk of reinfection, is COVID-19 here to stay? Disas Med Pub Health Prep 1. https://doi.org/10.1017/dmp.2020.274
Jabbari P, Jabbari F, Ebrahimi S, Rezaei N (2020) COVID-19: a chimera of two pandemics. Disaster Med Public Health Prep:1–2. https://doi.org/10.1017/dmp.2020.223
Jahanshahlu L, Rezaei N (2020a) Central nervous system involvement in COVID-19. Arch Med Res. https://doi.org/10.1016/j.arcmed.2020.05.016
Jahanshahlu L, Rezaei N (2020b) Monoclonal antibody as a potential anti-COVID-19. Biomed Pharmaco Biomed Pharmaco 129:110337. https://doi.org/10.1016/j.biopha.2020.110337
jean laurent casanova (2020, April) COVID human genetic efforts. https://www.covidhge.com/
Kafieh R, Arian R, Saeedizadeh N, Minaee S, Yadav SK, Vaezi A, Rezaei N, Javanmard SH (2020) COVID-19 in Iran: a deeper look into the future. medRxiv
Kivits J, Ricci L, Minary L (2019) Interdisciplinary research in public health: the ‘why’ and the ‘how’. J Epidemiol Community Health 73(12):1061–1062. https://doi.org/10.1136/jech-2019-212511
Konrad R, Eberle U, Dangel A, Treis B, Berger A, Bengs K, Fingerle V, Liebl B, Ackermann N, Sing A (2020) Rapid establishment of laboratory diagnostics for the novel coronavirus SARS-CoV-2 in Bavaria, Germany, February 2020. Euro Surv Bull Eur sur les maladies transmissibles Eur Comm Dis Bull 25(9). https://doi.org/10.2807/1560-7917.es.2020.25.9.2000173
Kowalski W, Walsh T, Petraitis V (2020) 2020 COVID-19 coronavirus ultraviolet susceptibility. https://doi.org/10.13140/RG.2.2.22803.22566
Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, Pan P, Wang W, Hu D, Liu X, Zhang Q, Wu J (2020a) Coronavirus infections and immune responses. J Med Virol 92(4):424–432. https://doi.org/10.1002/jmv.25685
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z (2020b) Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med 382(13):1199–1207. https://doi.org/10.1056/NEJMoa2001316
Li Z, Ge J, Yang M, Feng J, Qiao M, Jiang R, Bi J, Zhan G, Xu X, Wang L, Zhou Q, Zhou C, Pan Y, Liu S, Zhang H, Yang J, Zhu B, Hu Y, Hashimoto K, Jia Y, Wang H, Wang R, Liu C, Yang C (2020c) Vicarious traumatization in the general public, members, and non-members of medical teams aiding in COVID-19 control. Brain Behav Immun:S0889-1591(0820)30309-30303. https://doi.org/10.1016/j.bbi.2020.03.007
Liu X, Kakade M, Fuller CJ, Fan B, Fang Y, Kong J, Guan Z, Wu P (2012) Depression after exposure to stressful events: lessons learned from the severe acute respiratory syndrome epidemic. Compr Psychiatry 53(1):15–23. https://doi.org/10.1016/j.comppsych.2011.02.003
Livingston E, Desai A, Berkwits M (2020) Sourcing personal protective equipment during the COVID-19 pandemic. JAMA. https://doi.org/10.1001/jama.2020.5317
Lotfi M, Rezaei N (2020) SARS-CoV-2: a comprehensive review from pathogenicity of the virus to clinical consequences. J Med Virol. https://doi.org/10.1002/jmv.26123
Lotfi M, Hamblin MR, Rezaei N (2020) COVID-19: transmission, prevention, and potential therapeutic opportunities. Clinica Chim Acta Int J Clin Chem 508:254–266. https://doi.org/10.1016/j.cca.2020.05.044
Mallapaty S (2020) How sewage could reveal true scale of coronavirus outbreak. Nature 580(7802):176–177. https://doi.org/10.1038/d41586-020-00973-x
Mansourabadi AH, Sadeghalvad M, Mohammadi-Motlagh HR, Rezaei N (2020) The immune system as a target for therapy of SARS-CoV-2: a systematic review of the current immunotherapies for COVID-19. Life Sci 258:118185. https://doi.org/10.1016/j.lfs.2020.118185
Medicine Io (2006) Reusability of facemasks during an influenza pandemic: facing the flu. The National Academies Press, Washington, DC. https://doi.org/10.17226/11637
Merad M, Martin JC (2020) Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. https://doi.org/10.1038/s41577-020-0331-4
Ming R-X, Liu J, Cheung WKW, Wan X (2016) Stochastic modelling of infectious diseases for heterogeneous populations. Infect Dis Poverty 5(1):107. https://doi.org/10.1186/s40249-016-0199-5
Moazzami B, Razavi-Khorasani N, Dooghaie Moghadam A, Farokhi E, Rezaei N (2020) COVID-19 and telemedicine: immediate action required for maintaining healthcare providers well-being. J Clin Virol Off Publ Pan Am Soc Clin Virol 126:104345. https://doi.org/10.1016/j.jcv.2020.104345
Mohamed K, Rodríguez-Román E, Rahmani F, Zhang H, Ivanovska M, Makka SA, Joya M, Makuku R, Islam MS, Radwan N, Rahmah L, Goda R, Abarikwu SO, Shaw M, Zoghi S, Irtsyan S, Ling I, Cseprekal O, Faten A-B, Hazar Sayar E, Soloukey C, Grancini G, Rezaei N (2020a) Borderless collaboration is needed for COVID-19 – a disease that knows no borders. Infect Cont Hosp Epidemiol:1–2
Mohamed K, Rodríguez-Román E, Rahmani F, Zhang H, Ivanovska M, Makka SA, Joya M, Makuku R, Islam MS, Radwan N, Rahmah L, Goda R, Abarikwu SO, Shaw M, Zoghi S, Irtsyan S, Ling I, Cseprekal O, Faten AB, Hazar Sayar E, Soloukey C, Grancini G, Rezaei N (2020b) Borderless collaboration is needed for COVID-19-A disease that knows no borders. Infect Cont Hosp Epidemiol:1–2. https://doi.org/10.1017/ice.2020.162
Mohamed K, Yazdanpanah N, Saghazadeh A, Rezaei N (2020c) Computational drug discovery and repurposing for the treatment of Covid-19: a systematic review. Available at SSRN 3583748
Momtazmanesh S, Ochs HD, Uddin LQ, Perc M, Routes JM, Vieira DN, Al-Herz W, Baris S, Prando C, Rosivall L, Abdul Latiff AH, Ulrichs T, Roudenok V, Aldave Becerra JC, Salunke DB, Goudouris E, Condino-Neto A, Stashchak A, Kryvenko O, Stashchak M, Bondarenko A, Rezaei N (2020) All together to fight COVID-19. Am J Trop Med Hyg 102(6):1181–1183. https://doi.org/10.4269/ajtmh.20-0281
Moradian N, Ochs HD, Sedikies C, Hamblin MR, Camargo CA, Martinez JA, Biamonte JD, Abdollahi M, Torres PJ, Nieto JJ, Ogino S, Seymour JF, Abraham A, Cauda V, Gupta S, Ramakrishna S, Sellke FW, Sorooshian A, Wallace Hayes A, Martinez-Urbistondo M, Gupta M, Azadbakht L, Esmaillzadeh A, Kelishadi R, Esteghamati A, Emam-Djomeh Z, Majdzadeh R, Palit P, Badali H, Rao I, Saboury AA, Jagan Mohan Rao L, Ahmadieh H, Montazeri A, Fadini GP, Pauly D, Thomas S, Moosavi-Movahed AA, Aghamohammadi A, Behmanesh M, Rahimi-Movaghar V, Ghavami S, Mehran R, Uddin LQ, Von Herrath M, Mobasher B, Rezaei N (2020) The urgent need for integrated science to fight COVID-19 pandemic and beyond. J Transl Med 18(1):205. https://doi.org/10.1186/s12967-020-02364-2
Morlacco A, Motterle G, Zattoni F (2020) The multifaceted long-term effects of the COVID-19 pandemic on urology. Nat Rev Urol. https://doi.org/10.1038/s41585-020-0331-y
Nasab MG, Saghazadeh A, Rezaei N (2020) SARS-CoV-2-a tough opponent for the immune system. Arch Med Res. https://doi.org/10.1016/j.arcmed.2020.05.020
Okumus F, Mv N, Koseoglu MA, Bilgihan A (2018) Interdisciplinary research in tourism. Tour Manag 69:540–549. https://doi.org/10.1016/j.tourman.2018.05.016
Organization, PAH (2020, April 30) COVID-19 factsheets: understanding the infodemic and misinformation in the fight against COVID-19
Oxford Economics (2020, March 31) Global economic prospects: coronavirus inflicts a short, sharp recession on world economy. http://resources.oxfordeconomics.com/world-economic-prospects-executive-summary
Parmet WE, Sinha MS (2020) Covid-19 – the law and limits of quarantine. N Engl J Med. https://doi.org/10.1056/NEJMp2004211
Pashaei M, Rezaei N (2020) Immunotherapy for SARS-CoV-2: potential opportunities. Expert Opin Biol Ther:1–5. https://doi.org/10.1080/14712598.2020.1807933
Pourahmad R, Moazzami B, Rezaei N (2020) Efficacy of plasmapheresis and immunoglobulin replacement therapy (IVIG) on patients with COVID-19. SN Comprehen Clin Med:1–5
Qu G, Li X, Hu L, Jiang G (2020) An imperative need for research on the role of environmental factors in transmission of novel coronavirus (COVID-19). Environ Sci Technol. https://doi.org/10.1021/acs.est.0c01102
Rabiee N, Rabiee M, Bagherzadeh M, Rezaei N (2020) COVID-19 and picotechnology: potential opportunities. Med Hypotheses 144:109917. https://doi.org/10.1016/j.mehy.2020.109917
Rafa de Miguel EM, Pacho L, Ayuso S, Ferrer I (2020, March 30) Tracking the coronavirus: why does each country count deaths differently? https://english.elpais.com/society/2020-03-30/tracking-the-coronavirus-why-does-each-country-count-deaths-differently.html
Remuzzi A, Remuzzi G (2020) COVID-19 and Italy: what next? Lancet (London, England). doi:https://doi.org/10.1016/s0140-6736(20)30627-9
Rezaei N (2020a) COVID-19 affects healthy pediatricians more than pediatric patients. Infect Cont Hosp Epidemiol:1. https://doi.org/10.1017/ice.2020.139
Rezaei N (2020b) COVID-19 and medical biotechnology. Avicenna J Med Biotechnol 12(3):139
Rihan FA, Anwar MN (2012) Qualitative analysis of delayed SIR epidemic model with a saturated incidence rate. https://doi.org/10.1155/2012/408637
Rismanbaf A (2020) Potential treatments for COVID-19; a narrative literature review. Arch Acad Emerg Med 8(1):e29–e29
Rodriguez-Morales AJ, Cardona-Ospina JA, Gutierrez-Ocampo E, Villamizar-Pena R, Holguin-Rivera Y, Escalera-Antezana JP, Alvarado-Arnez LE, Bonilla-Aldana DK, Franco-Paredes C, Henao-Martinez AF, Paniz-Mondolfi A, Lagos-Grisales GJ, Ramirez-Vallejo E, Suarez JA, Zambrano LI, Villamil-Gomez WE, Balbin-Ramon GJ, Rabaan AA, Harapan H, Dhama K, Nishiura H, Kataoka H, Ahmad T, Sah R (2020) Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Trav Med Infect Dis:101623. https://doi.org/10.1016/j.tmaid.2020.101623
Rokni M, Hamblin MR, Rezaei N (2020) Cytokines and COVID-19: friends or foes? Hum Vaccin Immunother:1–3
roland Oliphant (2020, March 31) Counting coronavirus: how are different countries calculating death tolls, and can you trust them? https://www.telegraph.co.uk/news/2020/03/31/counting-coronavirus-different-countries-calculating-death-tolls/
Rzymski P, Nowicki M, Mullin GE, Abraham A, Rodríguez-Román E, Petzold MB, Bendau A, Sahu KK, Ather A, Naviaux A-F (2020) Quantity does not equal quality: scientific principles cannot be sacrificed. Int Immunopharmacol 86:106711
Saccucci M, Bruni E, Uccelletti D, Bregnocchi A, Sarto MS, Bossù M, Di Carlo G, Polimeni A (2018) Surface disinfections: present and future. J Nanomater 2018:8950143. https://doi.org/10.1155/2018/8950143
Saghazadeh A, Rezaei N (2020a) Immune-epidemiological parameters of the novel coronavirus – a perspective. Expert Rev Clin Immunol 16(5):465–470. https://doi.org/10.1080/1744666x.2020.1750954
Saghazadeh A, Rezaei N (2020b) Towards treatment planning of COVID-19: rationale and hypothesis for the use of multiple immunosuppressive agents: anti-antibodies, immunoglobulins, and corticosteroids. Int Immunopharmacol 84:106560. https://doi.org/10.1016/j.intimp.2020.106560
Sahu KK, Siddiqui AD, Rezaei N, Cerny J (2020) Challenges for management of immune thrombocytopenia during COVID-19 pandemic. J Med Virol. https://doi.org/10.1002/jmv.26251
Saleki K, Banazadeh M, Saghazadeh A, Rezaei N (2020) The involvement of the central nervous system in patients with COVID-19. Rev Neurosci 31(4):453–456. https://doi.org/10.1515/revneuro-2020-0026
Seno H, Dansu E (2019) A model for epidemic dynamics in a community with visitor subpopulation
Shamshirian D, Rezaei N (2020) Cardiovascular diseases burden in COVID-19: systematic review and meta-analysis
Sharifkashani S, Bafrani MA, Khaboushan AS, Pirzadeh M, Kheirandish A, Yavarpour Bali H, Hessami A, Saghazadeh A, Rezaei N (2020) Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: potential therapeutic targeting. Eur J Pharmacol 884:173455. https://doi.org/10.1016/j.ejphar.2020.173455
Sheera Frenkel DA, Zhong R (2020, March 8) Surge of virus misinformation stumps Facebook and Twitter. https://www.nytimes.com/2020/03/08/technology/coronavirus-misinformation-social-media.html
Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R (2020) COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J Adv Res 24:91–98. https://doi.org/10.1016/j.jare.2020.03.005
Siettos CI, Russo L (2013) Mathematical modeling of infectious disease dynamics. Virulence 4(4):295–306. https://doi.org/10.4161/viru.24041
Smith KM, Machalaba CC, Seifman R, Feferholtz Y, Karesh WB (2019) Infectious disease and economics: the case for considering multi-sectoral impacts. One Heal (Amsterdam, Netherlands) 7:100080. https://doi.org/10.1016/j.onehlt.2018.100080
Soheilypour M, Mofrad MRK (2018) Agent-based modeling in molecular systems biology. BioEssays News Rev Mol Cell Dev Biol 40(7):e1800020. https://doi.org/10.1002/bies.201800020
Speers DJ (2006) Clinical applications of molecular biology for infectious diseases. Clin Biochem Rev 27(1):39–51
Srinivasa Rao ASR, Vazquez JA (2020) Identification of COVID-19 can be quicker through artificial intelligence framework using a mobile phone-based survey when cities and towns are under quarantine. Infect Cont Hosp Epidemiol:1–5. https://doi.org/10.1017/ice.2020.61
The Lancet (2020) Palliative care and the COVID-19 pandemic. Lancet (London, England) 395(10231):1168–1168. https://doi.org/10.1016/S0140-6736(20)30822-9
Tu Y-F, Chien C-S, Yarmishyn AA, Lin Y-Y, Luo Y-H, Lin Y-T, Lai W-Y, Yang D-M, Chou S-J, Yang Y-P, Wang M-L, Chiou S-H (2020) A review of SARS-CoV-2 and the ongoing clinical trials. Int J Mol Sci 21(7):2657. https://doi.org/10.3390/ijms21072657
Uchenna A, Ossai O (2016) Use of contact isolation to prevent spread: ebola outbreak in a healthworkers base camp, Port Loko District, Sierra Leone, March 2015. Int J Infect Dis 45:216. https://doi.org/10.1016/j.ijid.2016.02.491
Velavan TP, Meyer CG (2020) The COVID-19 epidemic. Trop Med Int Heal TM & IH 25(3):278–280. https://doi.org/10.1111/tmi.13383
Vieta E, Pérez V, Arango C (2020) Psychiatry in the aftermath of COVID-19. Revista de Psiquiatría y Salud Mental. https://doi.org/10.1016/j.rpsm.2020.04.004
Warwick J, McKibbin, Fernando R (2020, March 2) The global macroeconomic impacts of COVID-19: seven scenarios. https://www.brookings.edu/research/the-global-macroeconomic-impacts-of-covid-19-seven-scenarios/
Weiss SR, Leibowitz JL (2011) Coronavirus pathogenesis. Adv Virus Res 81:85–164. https://doi.org/10.1016/b978-0-12-385885-6.00009-2
WHO (2020a, April 15) Coronavirus disease 2019 (COVID-19) situation report – 86. https://www.who.int/publications/i/item/coronavirus-disease-2019-(covid-19)
WHO (2020b, March 11) WHO Director-General’s opening remarks at the media briefing on COVID-19
WHO (2020c, May 27) Coronavirus disease (COVID-2019) situation reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
Wong DW, Oudit GY, Reich H, Kassiri Z, Zhou J, Liu QC, Backx PH, Penninger JM, Herzenberg AM, Scholey JW (2007) Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am J Pathol 171(2):438–451. https://doi.org/10.2353/ajpath.2007.060977
Yazdanpanah F, Hamblin MR, Rezaei N (2020a) The immune system and COVID-19: friend or foe? Life Sci 256:117900. https://doi.org/10.1016/j.lfs.2020.117900
Yazdanpanah N, Saghazadeh A, Rezaei N (2020b) Anosmia: a missing link in the neuroimmunology of coronavirus disease 2019 (COVID-19). Rev Neurosci. https://doi.org/10.1515/revneuro-2020-0039
Youn JS, Csavina J, Rine KP, Shingler T, Taylor MP, Sáez AE, Betterton EA, Sorooshian A (2016) Hygroscopic properties and respiratory system deposition behavior of particulate matter emitted by mining and smelting operations. Environ Sci Technol 50(21):11706–11713. https://doi.org/10.1021/acs.est.6b03621
Yousefi R, Moosavi-Movahedi AA (2020) Achilles’ heel of the killer virus: the highly important molecular targets for hitting SARS-CoV-2 that causes COVID-19. J Iran Chem Soc:1–2. https://doi.org/10.1007/s13738-020-01939-6
Yousefzadegan S, Rezaei N (2020) Case report: death due to COVID-19 in three brothers. Am J Trop Med Hyg 102(6):1203–1204. https://doi.org/10.4269/ajtmh.20-0240
Yu D, Poon SK, Tran V, Lam MK, Hines M, Brunner M, Power E, Shaw T, Togher L (2017) Enabler for interdisciplinary eHealthcare: a qualitative study. Stud Health Technol Inform 239:160–166
Zaim S, Chong JH, Sankaranarayanan V, Harky A (2020) COVID-19 and multi-organ response. Curr Probl Cardiol:100618. https://doi.org/10.1016/j.cpcardiol.2020.100618
Acknowledgments
We would like to thank Prof. Jagan Mohan Rao for his critical comments on this chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Moradian, N. et al. (2021). Interdisciplinary Approaches to COVID-19. In: Rezaei, N. (eds) Coronavirus Disease - COVID-19. Advances in Experimental Medicine and Biology, vol 1318. Springer, Cham. https://doi.org/10.1007/978-3-030-63761-3_52
Download citation
DOI: https://doi.org/10.1007/978-3-030-63761-3_52
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-63760-6
Online ISBN: 978-3-030-63761-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)